Home›Stock Screener›Cipla›Quarterly Results

Cipla Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹543 Cr
QMar 2026
Quarterly Results

In Mar 2026, Cipla (CIPLA) reported revenue ₹6,612 Cr and net profit ₹543 Cr — revenue -4.0% YoY. Analyse Cipla shareholding analysis to track promoter, FII and institutional holdings.

CIPLA Quarterly Results — Revenue, Profit & EPS Highlights

Cipla latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View CIPLA price range for the annual high/low range and current price position.

  • Revenue of ₹6,612 Cr in Mar 2026 (-9.3% vs Jun 2026, -4.0% vs Mar 2025)
  • Net Profit of ₹543 Cr in Mar 2026 (-30.9% vs Jun 2026, -55.3% vs Mar 2025)
  • EBITDA of ₹1,026 Cr in Mar 2026 (-24.6% vs Jun 2026)
  • Operating Margin of 14.0% in Mar 2026 (-2.0pp vs Jun 2026)
  • Earnings Per Share of ₹6.87 in Mar 2026 (-29.7% vs Jun 2026)

Cipla Quarterly Results — Revenue, EBITDA, Net Profit & EPS

CIPLA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 6,612 7,288 7,716 6,887 7,096 -9.3% -4.0%
Net Profit (₹ Cr) 543 786 1,353 1,214 1,292 - -
EBITDA (₹ Cr) 1,026 1,361 2,022 1,695 1,916 - -
EPS (₹) 6.87 9.77 16.73 15.13 16.07 - -
Operating Margin (%) 14.0% 16.0% 24.0% 21.0% 24.0% - -

CIPLA Share Price Trend — 1-Year Movement Across Quarterly Results

Cipla 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit CIPLA share price screener.

Profitability Ratios

Profit Margin 8.2%
EBITDA Margin 15.5%
Operating Margin 14.0%
ROE (Annual) 6.3%

Balance Sheet Highlights

Total Assets ₹42,496 Cr
Total Equity ₹34,520 Cr
Current Assets ₹24,146 Cr
Current Liabilities ₹962 Cr

Cash Flow Analysis

Operating Cash Flow ₹3,940 Cr
Investing Cash Flow ₹-2,234 Cr
Financing Cash Flow ₹-1,234 Cr
Net Cash Flow ₹473 Cr

Current Market Data

Current Price ₹1373.30
Exchange NSE
Last Updated Sep 10, 2026

Revenue Trend (₹ Cr)

Mar 2025 6,887
Sept 2025 7,716
Jun 2026 7,288
Mar 2026 6,612

Net Profit Trend (₹ Cr)

Mar 2025 1,214
Sept 2025 1,353
Jun 2026 786
Mar 2026 543

Operating Margin Trend (%)

Mar 2025 21.0%
Sept 2025 24.0%
Jun 2026 16.0%
Mar 2026 14.0%

CIPLA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Cipla latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹455,633.71 Cr 1861.0 15,018 2,710 -5.6% - 18.0% 164.7
Divis Laboratories
Mar 2026 		₹247,283.98 Cr 9438.5 2,986 751 -5.0% - 25.2% 333.4
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4930.0 4,111 364 +27.7% +42.2% 8.9% 428.3
Zydus Life Science
Mar 2026 		₹116,411.21 Cr 1117.8 7,569 1,341 -4.3% - 17.7% 88.4
Laurus Labs
Mar 2026 		₹105,131.67 Cr 1945.0 1,823 282 -10.5% - 15.5% 376.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores